Last Updated : June 17, 2019
Details
Generic Name:
pegaspargase
Project Status:
Not filed
Therapeutic Area:
Adult Acute Lymphocytic Leukemia (ALL)
Manufacturer:
Servier Canada Inc.
Brand Name:
Oncaspar
Project Line:
Reimbursement Review
Project Number:
NS0002-000
Submission Type:
Non-submission
Fee Schedule:
N/A
Indications:
Adult Acute Lymphocytic Leukemia (ALL)
Recommendation Type:
Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission.
Last Updated : June 17, 2019